This inventor holds 4 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignee: Bracco Imaging S.p.a.. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: The Innovative Contributions of Erika Reitano
Introduction
Erika Reitano is a prominent inventor based in Banchette, Italy. She has made significant contributions to the field of medical diagnostics and therapeutics, holding three patents that showcase her innovative spirit and dedication to advancing healthcare solutions.
Latest Patents
One of her latest patents is titled "CA-IX aptamers and diagnostic and therapeutic uses thereof." This invention provides nucleic acid aptamers that bind to the Carbonic Anhydrase IX (CA-IX) enzyme, along with derivatives and conjugates. These aptamers serve as diagnostic tools, particularly for imaging organs and tissues that express CA-IX, and as therapeutic agents for the prevention or treatment of CA-IX related diseases. Another notable patent is "Gene signatures for the prediction of prostate cancer recurrence." This patent discloses gene signatures and methods for predicting the recurrence of prostate cancer in subjects who have undergone prostatectomy. It also includes assay devices and kits for determining the expression levels of specific gene sets correlated to prostate cancer recurrence.
Career Highlights
Erika Reitano is currently associated with Bracco Imaging S.p.A., a company known for its commitment to innovation in medical imaging. Her work at Bracco Imaging has allowed her to focus on developing cutting-edge diagnostic tools that can significantly impact patient care.
Collaborations
Throughout her career, Erika has collaborated with notable colleagues, including Alessandro Maiocchi and Vittorio De Franciscis. These collaborations have further enriched her research and contributed to the success of her inventions.
Conclusion
Erika Reitano's innovative contributions to medical diagnostics and therapeutics highlight her role as a leading inventor in her field. Her patents not only advance scientific knowledge but also have the potential to improve patient outcomes in critical areas of healthcare.